《美国过敏性和感染性疾病所-Anti-HIV Compounds数据库》

  • 来源专题:艾滋病防治
  • 编译者: 李越
  • 发布时间:2006-01-17
  • This is the web of Niaid-Anti-HIV Compounds Database,which belong to the National Institute of Allergy and Infectious Diseases. This web site is currently divided into six sections:Viral Life Cycle,Viral Targets,Cellular Targets,FDA Approved Anti-HIV drugs,Anti-AIDS Drugs Listed by Class, Anti-AIDS Drugs Listed in Alphabetical Order.
  • 原文来源:http://www.niaid.nih.gov/daids/dtpdb/
相关报告
  • 《环境因素和过敏性疾病》

    • 来源专题:外来生物入侵
    • 编译者:王成卓
    • 发布时间:2019-06-17
    • 本文就影响变应性疾病(如哮喘、变应性鼻炎、特应性皮炎以及接触性皮炎)患病率和病程的各种环境因素的现代认识作一综述。周围的气候可能直接影响每个病人,但也决定了特定地理区域内动植物的种类,从而影响空气和食物过敏原的来源。流行病学研究表明,有一种强烈的空气污染与发展之间的关系和哮喘和其他过敏性疾病的恶化——主要的注意力一直集中在气态材料,如臭氧(O3)和二氧化氮(NO2),以及颗粒物(PM),汽车所产生的交通和工业。柴油废气颗粒物(DEP)具有与蛋白质结合的能力,可作为过敏原的潜在载体,深入呼吸道。最广泛研究的影响过敏的环境因素是空气中的过敏原:尘螨、花粉、真菌和动物皮屑。食物可能引起真正的ige介导的过敏,也可能引起各种非免疫反应,这些反应与直接释放介质或毒性活动有关。据估计,人类环境中有超过85000种化学物质,它们可能作为接触性过敏原或刺激物,导致过敏性或非过敏性接触性皮炎。其中,金属、香料、防腐剂、植物和对苯二胺被认为是最重要的。感染一直与变态反应性疾病的发病机制有关,它们可能会加重变态反应性疾病的病程。
  • 《非洲HIV-1/AIDS和其它感染性疾病的控制》

    • 来源专题:艾滋病防治
    • 编译者:李越
    • 发布时间:2005-03-07
    • The effect of HIV-1 on other infectious diseases in Africa is an increasing public health concern. In this review, we describe the role that three major infectious diseases—malaria, sexually transmitted diseases (STDs), and tuberculosis— have had in the HIV-1 epidemic. The high prevalence of untreated STD infections has been a major factor facilitating the spread of HIV-1 in Africa; with the synergistic interaction between HIV-1 transmission and genital herpes being of especial concern for control of both diseases. Increased susceptibility to tuberculosis after infection with HIV-1 has led to a rising incidence and threat of increased transmission of tuberculosis. Clinical malaria occurs with an increased frequency and severity in HIV-1-infected individuals, especially during pregnancy. As with tuberculosis, STDs, and other communicable HIV-1-associated diseases, the net effect of HIV-1 might include increased rates of malaria transmission across communities. In addition to enhancing access to HIV-1 prevention and care, public health surveillance and control programmes should be greatly intensified to cope with the new realities of infectious disease control in Africa.